Michael Cook mentions in this brief BioEdge post a couple of examples showing that "the bloom is off the rose" of embryonic stem cell research. The first is a January 17th editorial from Investor's Business Daily about the utter failure of California's $3 billion Proposition 71 ("When funding was needed, the phrase 'embryonic stem cells' was used. When actual progress was discussed, the word 'embryonic' was dropped because [the ESCR] never got out of the lab.") and the second is a January 19th Daily Mail story refering to even the International Society for Stem Cell Research admitting that "people’s expectations about stem cells are unrealistically high."
Monday, January 25, 2010
Enthusiasm Wanes for Embryonic Stem Cell Research
Michael Cook mentions in this brief BioEdge post a couple of examples showing that "the bloom is off the rose" of embryonic stem cell research. The first is a January 17th editorial from Investor's Business Daily about the utter failure of California's $3 billion Proposition 71 ("When funding was needed, the phrase 'embryonic stem cells' was used. When actual progress was discussed, the word 'embryonic' was dropped because [the ESCR] never got out of the lab.") and the second is a January 19th Daily Mail story refering to even the International Society for Stem Cell Research admitting that "people’s expectations about stem cells are unrealistically high."